Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05 04:00PM ET
36.88
Dollar change
-1.05
Percentage change
-2.77
%
IndexRUT P/E- EPS (ttm)-2.90 Insider Own9.24% Shs Outstand118.90M Perf Week-14.89%
Market Cap4.40B Forward P/E- EPS next Y-3.12 Insider Trans-9.43% Shs Float108.28M Perf Month-18.21%
Income-280.49M PEG- EPS next Q-0.76 Inst Own101.11% Short Float13.41% Perf Quarter-8.85%
Sales10.12M P/S434.79 EPS this Y3.40% Inst Trans15.98% Short Ratio11.64 Perf Half Y41.63%
Book/sh12.64 P/B2.92 EPS next Y-11.10% ROA-25.34% Short Interest14.52M Perf Year377.72%
Cash/sh13.31 P/C2.77 EPS next 5Y- ROE-27.76% 52W Range6.79 - 56.00 Perf YTD307.51%
Dividend Est.- P/FCF- EPS past 5Y-57.60% ROI-18.61% 52W High-34.14% Beta0.89
Dividend TTM- Quick Ratio17.76 Sales past 5Y148.90% Gross Margin73.78% 52W Low443.15% ATR (14)2.69
Dividend Ex-Date- Current Ratio17.76 EPS Y/Y TTM3.08% Oper. Margin-3209.35% RSI (14)33.55 Volatility5.32% 7.12%
Employees253 Debt/Eq0.01 Sales Y/Y TTM-0.19% Profit Margin-2772.45% Recom1.08 Target Price68.42
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q7.77% Payout- Rel Volume0.99 Prev Close37.93
Sales Surprise-42.61% EPS Surprise8.63% Sales Q/Q-17.10% EarningsNov 07 AMC Avg Volume1.25M Price36.88
SMA20-15.86% SMA50-18.04% SMA2001.74% Trades Volume1,229,177 Change-2.77%
Date Action Analyst Rating Change Price Target Change
Nov-26-24Initiated RBC Capital Mkts Outperform $67
Sep-24-24Initiated Goldman Buy $59
Aug-28-24Initiated Barclays Overweight $63
May-03-24Initiated BofA Securities Buy $40
Mar-14-24Initiated Cantor Fitzgerald Overweight $60
May-22-23Upgrade Evercore ISI In-line → Outperform $20
Mar-31-23Downgrade Evercore ISI Outperform → In-line $20
Jul-20-22Initiated Chardan Capital Markets Buy $29
Jul-12-22Initiated Raymond James Strong Buy $29
Sep-07-21Initiated Evercore ISI Outperform $50
Nov-26-24 10:00AM
Nov-21-24 04:05PM
Nov-13-24 04:07PM
Nov-12-24 07:00AM
Nov-07-24 06:10PM
04:05PM Loading…
04:05PM
Nov-06-24 10:00AM
04:27AM
Oct-31-24 09:00AM
Oct-30-24 08:00AM
Oct-21-24 04:05PM
Oct-18-24 08:00AM
Oct-04-24 07:00PM
10:53AM
Oct-03-24 07:00AM
06:27AM Loading…
Sep-29-24 06:27AM
Sep-26-24 07:34PM
Sep-25-24 09:00AM
Sep-23-24 04:05PM
Sep-05-24 09:00AM
Aug-28-24 09:00AM
Aug-21-24 04:05PM
Aug-20-24 07:44AM
Aug-19-24 09:00AM
Aug-14-24 08:30PM
Aug-13-24 04:01PM
Aug-09-24 08:53PM
05:20PM
04:17PM
04:05PM
07:00AM Loading…
07:00AM
Aug-05-24 09:15AM
09:00AM
Jul-24-24 06:41AM
Jul-23-24 07:00AM
Jul-22-24 04:05PM
Jul-03-24 06:53AM
Jun-24-24 04:05PM
Jun-21-24 04:05PM
Jun-20-24 09:00AM
Jun-17-24 04:05PM
Jun-14-24 09:00AM
Jun-13-24 08:00PM
10:39AM
Jun-12-24 04:04PM
04:01PM
07:45AM
07:00AM
May-29-24 04:05PM
08:45AM
May-23-24 06:00AM
May-21-24 04:05PM
May-19-24 09:03AM
May-17-24 03:24AM
May-15-24 09:00AM
May-09-24 11:55PM
04:05PM
May-08-24 04:05PM
12:27PM
06:00AM
Apr-22-24 04:05PM
Apr-04-24 01:30AM
Mar-27-24 09:00AM
Mar-21-24 04:05PM
Mar-15-24 07:01PM
Mar-04-24 04:02PM
07:00AM
Feb-29-24 12:00PM
07:00AM
Feb-28-24 05:20PM
04:40PM
04:05PM
Feb-27-24 09:00AM
Feb-26-24 06:55AM
Feb-21-24 04:05PM
Feb-20-24 09:00AM
Feb-15-24 05:00PM
Jan-29-24 08:54AM
Jan-22-24 04:05PM
Jan-05-24 08:30AM
Dec-21-23 04:05PM
Dec-13-23 08:30AM
Nov-29-23 09:03AM
Nov-28-23 10:09AM
10:02AM
07:01AM
06:30AM
Nov-21-23 04:05PM
09:00AM
Nov-08-23 06:12PM
04:05PM
Oct-23-23 04:05PM
Oct-07-23 07:30AM
Sep-26-23 09:00AM
Sep-25-23 09:00AM
Sep-21-23 04:05PM
Sep-11-23 07:28PM
Sep-07-23 09:00AM
Aug-31-23 09:00AM
Aug-30-23 09:00AM
Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McCarthy TeresaChief Human Resources OfficerNov 18 '24Option Exercise14.2225,000355,500119,018Nov 20 06:10 PM
McCarthy TeresaChief Human Resources OfficerNov 18 '24Sale41.1425,0001,028,52094,018Nov 20 06:10 PM
LEVIN ARTHUR ADirectorNov 19 '24Option Exercise1.243,3234,12118,153Nov 20 06:06 PM
LEVIN ARTHUR ADirectorNov 19 '24Sale42.123,323139,97314,830Nov 20 06:06 PM
MacLean Michael FChief Financial OfficerNov 06 '24Option Exercise8.4379,057666,064159,275Nov 08 04:50 PM
MacLean Michael FChief Financial OfficerNov 06 '24Sale45.56106,3194,843,97994,093Nov 08 04:50 PM
MICHAEL MACLEANOfficerNov 06 '24Proposed Sale45.09106,3194,793,924Nov 06 04:56 PM
LEVIN ARTHUR ADirectorOct 21 '24Option Exercise1.245,0006,20019,830Oct 23 04:19 PM
LEVIN ARTHUR ADirectorOct 21 '24Sale46.635,000233,16814,830Oct 23 04:19 PM
ARTHUR A LEVINDirectorOct 21 '24Proposed Sale50.458,323419,895Oct 21 04:21 PM
McCarthy TeresaChief Human Resources OfficerOct 16 '24Option Exercise14.2225,000355,500119,018Oct 17 04:20 PM
McCarthy TeresaChief Human Resources OfficerOct 16 '24Sale48.5225,0001,213,01094,018Oct 17 04:20 PM
LEVIN ARTHUR AOfficerOct 16 '24Proposed Sale46.6022,5001,048,500Oct 16 01:48 PM
Thompson TamarDirectorOct 07 '24Option Exercise27.6330,000828,90030,000Oct 09 05:23 PM
Thompson TamarDirectorOct 07 '24Sale44.9830,0001,349,2590Oct 09 05:23 PM
Thompson TamarOfficerOct 07 '24Proposed Sale47.3030,0001,419,000Oct 07 04:39 PM
Flanagan W. MichaelCSTOOct 01 '24Option Exercise26.7562,5001,671,875147,889Oct 03 04:09 PM
Flanagan W. MichaelCSTOOct 01 '24Sale47.6262,5002,976,11285,389Oct 03 04:09 PM
WILLIAM MICHAEL FLANAGANOfficerOct 01 '24Proposed Sale45.9338,0181,746,167Oct 01 04:36 PM
McCarthy TeresaChief Human Resources OfficerSep 23 '24Sale44.0013,153578,73769,018Sep 23 09:06 PM
Flanagan W. MichaelCSTOSep 23 '24Sale43.9525,0001,098,73372,718Sep 23 09:03 PM
Boyce SarahPresident and CEOSep 23 '24Sale44.0032,8801,446,723234,663Sep 23 09:01 PM
MacLean Michael FChief Financial OfficerSep 23 '24Sale44.0011,510506,44096,355Sep 23 08:59 PM
WILLIAM MICHAEL FLANAGANOfficerSep 23 '24Proposed Sale44.4836,3291,615,914Sep 23 04:27 PM
LEVIN ARTHUR ADirectorSep 19 '24Option Exercise1.245,0006,20019,830Sep 20 05:19 PM
LEVIN ARTHUR ADirectorSep 19 '24Sale45.735,000228,65814,830Sep 20 05:19 PM
Flanagan W. MichaelCSTOSep 11 '24Option Exercise25.2496,5002,435,855138,265Sep 13 04:25 PM
Flanagan W. MichaelCSTOSep 11 '24Sale40.40111,3944,500,24460,871Sep 13 04:25 PM
McCarthy TeresaChief Human Resources OfficerSep 11 '24Option Exercise14.2225,000355,50082,171Sep 13 04:17 PM
McCarthy TeresaChief Human Resources OfficerSep 11 '24Sale40.4025,0001,010,04257,171Sep 13 04:17 PM
WILLIAM MICHAEL FLANAGANOfficerSep 11 '24Proposed Sale40.79111,3944,543,761Sep 11 04:18 PM
TERESA MCCARTHYOfficerSep 11 '24Proposed Sale40.7975,0003,059,250Sep 11 04:18 PM
LEVIN ARTHUR ADirectorAug 19 '24Option Exercise1.245,0006,20019,830Aug 21 04:30 PM
LEVIN ARTHUR ADirectorAug 19 '24Sale45.195,000225,94614,830Aug 21 04:30 PM
Boyce SarahPresident and CEOAug 06 '24Option Exercise1.2428,00034,720233,043Aug 07 05:46 PM
Boyce SarahPresident and CEOAug 06 '24Sale43.3528,0001,213,822205,043Aug 07 05:46 PM
LEVIN ARTHUR ADirectorJul 19 '24Option Exercise1.245,0006,20019,830Jul 23 04:22 PM
LEVIN ARTHUR ADirectorJul 19 '24Sale45.015,000225,06914,830Jul 23 04:22 PM
Boyce SarahPresident and CEOJul 09 '24Option Exercise1.2428,00034,720233,043Jul 11 04:07 PM
Boyce SarahPresident and CEOJul 09 '24Sale39.9328,0001,118,082205,043Jul 11 04:07 PM
LEVIN ARTHUR ADirectorJun 20 '24Option Exercise1.245,0006,20019,830Jun 21 04:19 PM
LEVIN ARTHUR ADirectorJun 20 '24Sale37.595,000187,95014,830Jun 21 04:19 PM
McCarthy TeresaChief Human Resources OfficerJun 18 '24Sale39.139,864385,97232,171Jun 20 06:49 PM
MacLean Michael FChief Financial OfficerJun 18 '24Sale39.1311,228439,34557,865Jun 20 06:48 PM
Boyce SarahPresident and CEOJun 18 '24Sale39.1332,0741,255,040142,543Jun 20 06:47 PM
Flanagan W. MichaelCSTOJun 18 '24Sale39.1310,106395,44550,765Jun 20 06:47 PM
MacLean Michael FChief Financial OfficerJun 12 '24Option Exercise8.82104,245919,441148,338Jun 14 07:07 PM
MacLean Michael FChief Financial OfficerJun 12 '24Sale35.72104,2453,723,14144,093Jun 14 07:07 PM
LEVIN ARTHUR ADirectorJun 13 '24Sale40.0860,0002,404,782153,872Jun 14 07:03 PM
LEVIN ARTHUR ADirectorJun 12 '24Sale35.0740,0001,402,628213,872Jun 14 07:03 PM
Boyce SarahPresident and CEOJun 13 '24Option Exercise1.24164,233203,649276,350Jun 14 06:58 PM
Boyce SarahPresident and CEOJun 12 '24Option Exercise1.24100,000124,000212,117Jun 14 06:58 PM
Boyce SarahPresident and CEOJun 14 '24Option Exercise1.2435,76744,351147,884Jun 14 06:58 PM
Boyce SarahPresident and CEOJun 13 '24Sale40.08164,2336,581,802112,117Jun 14 06:58 PM
Boyce SarahPresident and CEOJun 12 '24Sale35.73100,0003,573,020112,117Jun 14 06:58 PM
Boyce SarahPresident and CEOJun 14 '24Sale40.0835,7671,433,484112,117Jun 14 06:58 PM
Boyce SarahPresident and CEOJun 04 '24Option Exercise1.2428,00034,720140,117Jun 05 05:46 PM
Boyce SarahPresident and CEOJun 04 '24Sale27.4228,000767,780112,117Jun 05 05:46 PM
LEVIN ARTHUR ADirectorMay 20 '24Option Exercise1.245,0006,20019,830May 21 05:05 PM
LEVIN ARTHUR ADirectorMay 20 '24Sale29.905,000149,48114,830May 21 05:05 PM
MacLean Michael FChief Financial OfficerMay 14 '24Option Exercise8.8275,000661,500119,093May 16 06:25 PM
MacLean Michael FChief Financial OfficerMay 14 '24Sale28.2875,0002,121,04544,093May 16 06:25 PM
Boyce SarahPresident and CEOMay 07 '24Option Exercise1.2428,00034,720140,117May 07 09:52 PM
Boyce SarahPresident and CEOMay 07 '24Sale25.5428,000715,050112,117May 07 09:52 PM
LEVIN ARTHUR ADirectorApr 19 '24Option Exercise1.245,0006,20019,830Apr 22 05:28 PM
LEVIN ARTHUR ADirectorApr 19 '24Sale22.825,000114,12314,830Apr 22 05:28 PM
LEVIN ARTHUR ADirectorApr 03 '24Sale27.1120,000542,214253,872Apr 03 08:26 PM
Boyce SarahPresident and CEOApr 02 '24Option Exercise1.2428,00034,720140,117Apr 03 06:16 PM
Boyce SarahPresident and CEOApr 02 '24Sale26.2528,000734,919112,117Apr 03 06:16 PM
LEVIN ARTHUR ADirectorMar 19 '24Option Exercise1.245,0006,20019,830Mar 21 04:10 PM
LEVIN ARTHUR ADirectorMar 19 '24Sale23.975,000119,84814,830Mar 21 04:10 PM
MacLean Michael FChief Financial OfficerMar 13 '24Option Exercise8.8240,000352,80084,093Mar 15 04:12 PM
MacLean Michael FChief Financial OfficerMar 13 '24Sale24.5240,000980,76044,093Mar 15 04:12 PM
LEVIN ARTHUR ADirectorMar 12 '24Option Exercise1.2425,00031,00042,471Mar 12 08:41 PM
LEVIN ARTHUR ADirectorMar 12 '24Sale22.0327,641609,01714,830Mar 12 08:41 PM
Boyce SarahPresident and CEOMar 08 '24Option Exercise1.2484,000104,160196,117Mar 12 05:29 PM
Boyce SarahPresident and CEOMar 12 '24Option Exercise1.2428,00034,720140,117Mar 12 05:29 PM
Boyce SarahPresident and CEOMar 08 '24Sale21.3984,0001,796,710112,117Mar 12 05:29 PM
Boyce SarahPresident and CEOMar 12 '24Sale22.6328,000633,682112,117Mar 12 05:29 PM
Boyce SarahPresident and CEOMar 01 '24Option Exercise1.2484,000104,160196,117Mar 05 04:53 PM
Boyce SarahPresident and CEOMar 01 '24Sale20.1384,0001,691,306112,117Mar 05 04:53 PM
LEVIN ARTHUR ADirectorJan 22 '24Sale10.131,85918,83217,471Jan 23 03:14 PM
Boyce SarahPresident and CEOJan 22 '24Sale10.135,09251,58244,008Jan 23 03:13 PM
Flanagan W. MichaelCSTOJan 22 '24Sale10.134,12941,82735,871Jan 23 03:12 PM
McCarthy TeresaChief Human Resources OfficerJan 22 '24Sale10.132,06520,91817,035Jan 23 03:11 PM
MacLean Michael FChief Financial OfficerJan 22 '24Sale10.131,61616,37016,884Jan 23 03:11 PM